Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | Director | May 26, 2022 | May 31, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date May 26, 2022 · Filed May 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,847 |
Reported balance
After 2022-05-26 transaction · row 1
1 source rowRow 1 · 2022-05-26 · Grant · Acquired 38,910 · Balance 68,847 F1: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 26, 2023, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 26, 2023, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2022 Filed May 31, 2022 16:28 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 38,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-013867 · form4.xml · nonDerivative · entry 1 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,847 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 26, 2023, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:17 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,797 | $0.00 Strike: $4.06 | $0.00 |
DisclosureSEC source: 0001062993-21-010979 · form4.xml · derivative · entry 3 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,321 Underlying: Common Stock · 7,797 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested and exercisable. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:17 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 7,797 | $5.30 | $41,324.10 |
DisclosureSEC source: 0001062993-21-010979 · form4.xml · nonDerivative · entry 2 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,937 Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:17 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 7,797 | $4.06 | $31,640.23 |
DisclosureSEC source: 0001062993-21-010979 · form4.xml · nonDerivative · entry 1 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 18:30 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 15,200 | $13.35 | $202,868.32 |
DisclosureSEC source: 0001062993-21-005249 · form4.xml · nonDerivative · entry 2 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,937 F3 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $12.92 to $13.93. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 18:30 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 7,137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-005249 · form4.xml · nonDerivative · entry 1 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,137 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 27, 2022, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 18:40 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 10,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000650 · edgar.xml · nonDerivative · entry 1 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) August 5, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 26, 2020 Filed Jun 26, 2020 16:19 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 27,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000562 · edgar.xml · nonDerivative · entry 1 Shook Bruce Joseph · CIK 0001816026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 26, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.